Personalized oncology, humanized immune models and AI-powered multi-omics are driving PDX adoption, enhancing biomarker validation and drug development success.Dublin, Oct. (GLOBE NEWSWIRE) -- ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results